Dr. Robert Alter, MD
Claim this profileHackensack University Medical Center
Area of expertise
Bladder Cancer
Robert Alter, MD has run 6 trials for Bladder Cancer. Some of their research focus areas include:
Kidney Cancer
Robert Alter, MD has run 5 trials for Kidney Cancer. Some of their research focus areas include:
Affiliated Hospitals
Hackensack University Medical Center
John Theurer Cancer Center
Clinical Trials Robert Alter, MD is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
Durvalumab + Chemotherapy
for Urothelial Carcinoma
This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone.
Recruiting
1 award
Phase 2 & 3
10 criteria
More about Robert Alter, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Robert Alter, MD has experience with
- Nivolumab
- Ipilimumab
- Atezolizumab
- Prednisone
- Cabozantinib
- Radiation Therapy
Breakdown of trials Robert Alter, MD has run
Bladder Cancer
Kidney Cancer
Prostate Cancer
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Alter, MD specialize in?
Robert Alter, MD focuses on Bladder Cancer and Kidney Cancer. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Robert Alter, MD currently recruiting for clinical trials?
Yes, Robert Alter, MD is currently recruiting for 5 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Robert Alter, MD has studied deeply?
Yes, Robert Alter, MD has studied treatments such as Nivolumab, Ipilimumab, Atezolizumab.
What is the best way to schedule an appointment with Robert Alter, MD?
Apply for one of the trials that Robert Alter, MD is conducting.
What is the office address of Robert Alter, MD?
The office of Robert Alter, MD is located at: Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.